Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-05

Clinical Trial Update: Insulin Degludec vs Insulin Glargine for Glycemic Control in Critical Illness Hyperglycemia [NA]

View source ↗

Summary

A completed clinical trial comparing insulin degludec to insulin glargine for glycemic control in patients with hyperglycemia during critical illness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin Glargine (insulin glargine)
  • insulin degludec (insulin degludec)

Snippet

Sponsor: Ain Shams University | Conditions: Glycemic Control, Insulin | NA | Status: COMPLETED